Clinical Trial Update: Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating escitalopram combination therapy for adults with major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Lexapro (escitalopram)

Snippet

Sponsor: Forest Laboratories | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED